Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Oncology Institute (TOI) Preferred Shares Issued (2021)

Oncology Institute (TOI) has disclosed Preferred Shares Issued for 1 consecutive years, with $20.0 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Preferred Shares Issued changed N/A year-over-year to $20.0 million, compared with a TTM value of $20.0 million through Dec 2021, changed N/A, and an annual FY2021 reading of $20.0 million, changed N/A over the prior year.
  • Preferred Shares Issued was $20.0 million for Q1 2021 at Oncology Institute.
  • Across five years, Preferred Shares Issued topped out at $20.0 million in Q1 2021 and bottomed at $20.0 million in Q1 2021.